Pharmacology, Toxicology and Pharmaceutical Science
Drospirenone
55%
Estetrol
55%
Menopausal Syndrome
55%
Activated Protein C Resistance
55%
Menopause
55%
Ethinylestradiol
41%
Clotting Time
41%
Venous Thromboembolism
27%
Estrogen
23%
Nuclear Estrogen
22%
Membrane Estrogen
22%
Levonorgestrel
20%
Progestin
15%
Genetic Disorder
13%
Blood Clotting Factor 8
13%
Hormone
13%
F Factor
13%
Tolerability
13%
Hemostatic Agent
13%
Protein S Deficiency
13%
Gestodene
7%
Contraceptive Agent
7%
Activated Protein C
7%
Desogestrel
7%
Liver Protein
7%
Oral Contraceptive Agent
6%
Drospirenone Plus Ethinylestradiol
6%
Procoagulant
6%
Medicine and Dentistry
Drospirenone
55%
Estetrol
55%
Oral Contraceptive
55%
Satisfaction
27%
Arm
27%
Thrombogenicity
22%
Levonorgestrel
20%
Liver Function
13%
Carbohydrate Metabolism
13%
Gestagen
13%
Hemostat
11%
Prothrombin G20210A
11%
Heredity
11%
CYP2C9
11%
Oral Contraceptive Use
11%
Antifibrinolytic
11%
Factor V Leiden
11%
Hormone Therapy
11%
Protein S Deficiency
11%
Blood Clotting Inhibitor
11%
Blood Group O
11%
Oral Contraceptive Agent
6%
Antithrombotic
6%
Endocrine Function
6%
Procoagulant
6%
Drospirenone Plus Ethinylestradiol
6%
Activated Protein C Resistance
5%
Immunology and Microbiology
Thrombin
100%
Laboratory Test
55%
Electric Potential
55%
Blood Plasma
33%
Clotting Time
33%
Screening Test
22%
Sample
11%
Factor VIII
11%
Development
11%
Genetic Screening
11%
Pregnancy
11%
Fertility Factor
11%